MedTrace Logo

St. Vincent's Screening To Prevent Heart Failure Study

NCT00921960 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1378

Last updated 2018-07-27

No results posted yet for this study

Summary

The STOP-HF study is a prospective, randomized, controlled trial recruiting asymptomatic individuals with risk factors for left ventricular dysfunction from 50 primary care clinics in Dublin and south east Ireland. It is designed to determine whether using natriuretic peptide measurement as a screening tool following a general cardiovascular risk factor screen will reduce the prevalence and severity of ventricular dysfunction in conjunction with specialist follow-up at St. Vincent's University Hospital.

Conditions

Interventions

OTHER

Intervention Care

Intervention Care is defined as a collaborative cardiovascular management between primary care and specialist hospital based services. This will involve natriuretic peptide guided evaluation of LVD and follow-up as appropriate - for example including echocardiographic assessment of left ventricular systolic dysfunction and appropriate pharmacotherapy.

Sponsors & Collaborators

  • University College Dublin

    collaborator OTHER

  • Crofton Cardiac Centre, Dublin

    collaborator UNKNOWN

  • The Heartbeat Trust

    collaborator OTHER

  • St Vincent's University Hospital, Ireland

    lead OTHER

Principal Investigators

  • Kenneth M McDonald, MD · St Vincent's University Hospital

  • Mark T Ledwidge, PhD · St Vincent's University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00921960 on ClinicalTrials.gov